Novavax Inc. said it would cut nearly a third of its workforce in a sweeping restructuring of its business and the drug developer reported revenue more than halved, faring much worse than anticipated in a quarter already marred by disappointing clinical trial results.
Baca Berita Asal
Bagikan Berita Ini
0 Response to "Novavax to Cut 30% of Workforce"
Post a Comment